Divisadero Street Capital Management’s Haemonetics HAE Stock Holding History

Divisadero Street Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.23M	Buy	+96,459	New	+$6.2M	0.16%	69

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Divisadero Street Capital Management's HAE Position: Q2 2026 in Review

Divisadero Street Capital Management opened a new position in Haemonetics (HAE) in Q2 2026: 96,459 shares worth $7.23M. The stake represents 0.16% of the portfolio and ranks #69 among its holdings.

329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Divisadero Street Capital Management held 96,459 shares of Haemonetics worth $7.23M as of Q2 2026.
Haemonetics was a new Divisadero Street Capital Management position in Q2 2026.
Haemonetics made up 0.16% of Divisadero Street Capital Management's portfolio in Q2 2026, its #69 holding.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Divisadero Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.